A U.S. District Court judge in Florida recently dismissed a number of claims against generic manufacturers of Zantac products, as well as various packagers, retailers, and distributors of the products. Ranitidine is the active ingredient in the heartburn medications and is at the center of a firestorm of controversy over concerns of contamination with a carcinogenic compound called N-nitrosodimethylamine, or NDMA.
Thousands of plaintiffs across ...
continue reading...